Please continue to check Important Medicare Advantage Updates at anthem.com/ca/medicareprovider for the latest Medicare Advantage information, including:

 

Prior authorization requirements for high-level definitive drug testing

Prior authorization requirements for Part B drugs: Moxetumomab Pasudotox, Cemiplimab and Fulphila  

July Medicare Advantage reimbursement policy  

Submit PA medication requests electronically; new phone number for MA prescription PAs 

MA members receive incentives for completing screenings

CMS issues regulatory changes for short- and long-acting narcotics; days’ supply limits effective Jan. 1, 2019  

Inpatient Readmissions   



Featured In:
October 2018 Anthem Blue Cross Provider Newsletter - California